NEW YORK (GenomeWeb News) – LGC Genomics and Covaris announced late on Wednesday a partnership to develop solutions for the high-throughput extraction of nucleic acids from formalin-fixed, paraffin-embedded tissue samples.

The firms will integrate LGC Genomics' DNA purification solution with Covaris' FFPE extraction workflow to offer "a complete solution, from FFPE tissue to high quality DNA, suitable for high-throughput applications with the ability to process thousands of FFPE samples per week," they said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.